PURPOSE: Low, intermediate and high risk categories have been defined to help guide the treatment of patients with nonmuscle invasive bladder cancer (Ta, T1, CIS). However, while low and high risk disease has been well classified, the intermediate risk category has traditionally comprised a heteroge...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!